LDB3 and breast cancer: These clinical and basic studies have shown that most members of PDLIMs (except for PDLIM6) are aberrantly expressed in a range of tumors, including lung cancer (LC), breast cancer (BC), and gastric cancer (GC), and are involved in the functional regulation of pathophysiology in a variety of tumors.